Following treatment with MSEOs, the mRNA levels of GABAARα1, GABAARγ2, and 5HT-2A in brain tissue of the three different concentrations of MSEOs treatment groups showed varying degrees of upregulation when compared to the insomnia model group. The gene discussed is HTR2A; the disease is insomnia measurement.